Search results
Results from the Think 24/7 Content Network
3,4-Methylenedioxyamphetamine (also known as MDA and sass) is an empathogen-entactogen, psychostimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug. In its pharmacology, MDA is a serotonin–norepinephrine–dopamine releasing agent (SNDRA). In most countries, the drug is a controlled ...
Mephedrone. Not to be confused with methedrine, methedrone, mephedrene, methadone, methylone, methcathinone, or ephedrone. Mephedrone, also known as 4-methylmethcathinone, 4-MMC, and 4-methylephedrone, is a synthetic stimulant drug of the amphetamine and cathinone classes. Slang names include drone, [ 5 ]M-CAT, [ 6 ]White Magic, [ 7 ]meow meow ...
MDAI (5,6-methylenedioxy-2-aminoindane) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non- neurotoxic and highly selective serotonin releasing agent (SSRA) in vitro and produces entactogen effects in humans.
1 Kancha = 5 Siki. 1 Chhataank = 4 Kancha. 1 Chhataank = 5 Bhari. 1 Adh-pav = 2 Chhatank = 1/8 Seer. 1 Pav = 2 Adh-pav = ¼ Seer (Pav means ¼) The unit pav is still used to this date however, it has been modified to "a fourth of a kilogram". 1 Adher = 2 Pav = ½ Seer. In Hindi ½ Seer = Adha (½) Seer, or Adher.
2-Aminoindane ( 2-AI) is a research chemical with applications in neurologic disorders and psychotherapy that has also been sold as a designer drug. [1] It acts as a selective substrate for NET and DAT. [2] [3]
MMDA (drug) MMDA ( 3-methoxy-4,5-methylenedioxyamphetamine; 5-methoxy-MDA) is a psychedelic and entactogen drug of the amphetamine class. It is an analogue of lophophine, MDA, and MDMA . MMDA was described by Alexander Shulgin in his book PiHKAL. Shulgin lists the dosage range of MMDA as 100–250 mg. The first effects appear within 30–60 ...
MDMAI. 5,6-Methylenedioxy-N-methyl-2-aminoindane ( MDMAI ), is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non- neurotoxic and highly selective serotonin releasing agent (SSRA) in animals and a putative entactogen in humans. [1]
With selegiline at a oral dose of 10 mg, levmetamfetamine and levoamphetamine are eliminated in urine and recovery of levmetamfetamine is 20 to 60% (or about 2–6 mg) while that of levoamphetamine is 9 to 30% (or about 1–3 mg).